Dongfeng Motor Group Co. Ltd. ADS (DNFGY) Financials Nov
Dongfeng Motor Group Co. Ltd. ADS (DNFGY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dongfeng Motor Group Co. Ltd. ADS
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 104.12B 140.5B 158.29B 7.49B 47.02B
Cost of Goods Sold (COGS) incl. D&A 84.28B 110.24B 126.51B 7.05B 41.11B
COGS excluding D&A 81.21B 105.63B 122.71B 6.79B 40.12B
Depreciation & Amortization Expense 3.08B 4.6B 3.79B 260.63M 986.66M
Depreciation 2.63B 4.12B 3.28B 238.5M 918.53M
Amortization of Intangibles 416.45M 458.01M 468.46M 12.29M 44.16M
Gross Income 19.84B 30.26B 31.78B 435.2M 5.91B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.44B 11.48B 16.14B 2.61B 7.75B
Research & Development 2.37B 3.01B 4.17B 747.46M 2.06B
Other SG&A 6.07B 8.47B 11.97B 1.86B 5.69B
Other Operating Expense 3.53B 4.79B 1.24B 0 0
Unusual Expense 175.89M 387.99M 221.58M - (47.95M)
EBIT after Unusual Expense (175.89M) (387.99M) (221.58M) - 47.95M
Non Operating Income/Expense 1.5B 2.27B 1.87B 566.74M 480.71M
Non-Operating Interest Income 401.7M 779.43M 1.27B 735.16M 686.37M
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 278.01M 262.87M 484.11M 218.83M 214.49M
Gross Interest Expense 351.77M 291.57M 519.04M 218.83M 214.49M
Interest Capitalized 73.76M 28.7M 34.92M 0 0
Pretax Income 9.32B 16.4B 16.84B (1.12B) (904.65M)
Income Tax 1.9B 3.45B 4.1B 55.32M 137.53M
Income Tax - Current Domestic 2.57B 4.41B 4.69B 59.01M 971.52M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (676.31M) (964.24M) (596.11M) (3.69M) (834M)
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 221.28M 339.78M 456.41M 12.37B 14.42B
Other After Tax Income (Expense) 0 0 - 0 0
Consolidated Net Income 7.65B 13.29B 13.2B 11.2B 13.38B
Minority Interest Expense 553.76M 684.15M 576.84M 18.44M 94.63M
Net Income 7.09B 12.61B 12.62B 11.18B 13.28B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 7.09B 12.61B 12.62B 11.18B 13.28B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 7.09B 12.61B 12.62B 11.18B 13.28B
EPS (Basic) 0.82 1.46 1.47 1.30 1.54
Basic Shares Outstanding 8.62B 8.62B 8.62B 8.62B 8.62B
EPS (Diluted) 0.82 1.46 1.47 1.30 1.54
Diluted Shares Outstanding 8.62B 8.62B 8.62B 8.62B 8.62B
EBITDA 10.95B 18.6B 18.2B (1.91B) (857.97M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Inflation Trends and Risks Monitoring inflation trends has become increasingly important in the current economic climate, where the Consumer Price Index (CPI) had previously surged to 9.0%. Now, with inflation levels around 2.7%, many are left observing potential shifts in macroeconomic conditions. As government policies shift, especially with new leadership...
Continue Reading
Cornish Metals Strengthens Its Financial Position Vancouver-based Cornish Metals Inc. (TSX-V: CUSN, LSE: CUSN) is excited to announce a significant move to bolster its financial stature. The company, known for its focus on mineral exploration and development, specifically its permitted South Crofty tin project, has exercised stock options resulting in the issuance of...
Continue Reading
Jackson Physician Search Celebrated as a Premier Workplace Jackson Physician Search has achieved an impressive milestone by earning No. 2 ranking among medium-sized companies and eighth overall in the esteemed healthcare sector, in the annual Modern Healthcare awards for best places to work. This announcement follows the company's remarkable ten consecutive years on this...
Continue Reading
Revolutionizing AI Applications with CAMARA and MCP CAMARA, an open-source community project, is leading the charge in bridging artificial intelligence (AI) with telecommunication networks via modern APIs. Their innovative approach is outlined in a newly released white paper asserting the capabilities of their Model Context Protocol (MCP) combined with network APIs. The...
Continue Reading
Cohen & Steers Infrastructure Fund Overview Cohen & Steers Infrastructure Fund, Inc. (NASDAQ: UTF) provides valuable investment options focusing on infrastructure. As an influential player in capital assets, the Fund aims to meet the needs of investors looking for sustainable income and growth. Understanding the sources of distribution is essential for shareholders...
Continue Reading